AI Robot “Alter Ego” Tested in Milan Hospital to Assist Patients
A robotic assistant named “Alter Ego” is being tested at the Maugeri Hospital in Milan to support healthcare workers by performing basic tasks, according to a collaboration between the Italian Institute of Technology and the University of Pisa. The 1.2-meter-tall robot, designed to interact with patients, has been in trials since April in a department treating amyotrophic lateral sclerosis (ALS) patients, a neurodegenerative disease.
What is the Alter Ego Robot?
Developed by the Italian Institute of Technology and the University of Pisa, Alter Ego is a humanoid robot equipped with expressive eyebrows and the ability to communicate with patients. It can assist with tasks such as delivering water, guiding patients to treatment rooms, and relaying pain levels to medical staff. The robot is currently controlled remotely but will transition to autonomous operation in July, as reported by the hospital’s rehabilitation neuromotor department.
How Is the Robot Being Tested?
Since April, Alter Ego has been deployed in a Milan hospital’s ALS department, where patients like 31-year-old Daniel Senna use a chest-mounted screen to input their pain levels. The robot, named Ego, asks patients questions and transmits data to nursing staff. Christian Lunetta, head of the rehabilitation department, noted initial concerns about patient reactions but stated that results have been “very satisfactory.” The robot’s design aims to spark curiosity and demonstrate versatile applications in healthcare settings.
Why Is This Development Significant?
The trial highlights the growing role of AI in healthcare, particularly in reducing the workload of medical staff. Manuel Catalano, a researcher at the Italian Institute of Technology, emphasized that the project seeks to understand the boundaries of robotic assistance in hospitals. While the robot cannot yet administer medication, it may help patients feel more empowered to request assistance directly, potentially easing the burden on caregivers. Rachele Piras, a neurologist, noted that delegating tasks like pill distribution remains a future challenge.
What Are the Future Plans for the Robot?
If successful, Alter Ego could extend its role beyond hospitals to support patients and caregivers in their homes. The hospital’s rehabilitation team aims to refine the robot’s capabilities, focusing on repetitive tasks that could free up human staff for more personalized care. Lunetta stated that hospitals “have many repetitive tasks” that “could be delegated to a capable robot,” allowing healthcare workers to prioritize patient relationships.
How Does This Fit Into Broader AI Trends?
The project aligns with global advancements in AI-driven robotics, though experts caution that autonomous systems require extensive training to operate without supervision. According to a 2023 report by the European Commission, healthcare robotics are expected to grow by 15% annually through 2030, driven by aging populations and labor shortages. Alter Ego’s trial reflects this trend, offering a glimpse into how AI might reshape patient care in the coming years.
For more details, visit the Italian Institute of Technology and University of Pisa websites.